Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population

ClinicalTrials.gov ID: NCT00425594

Public ClinicalTrials.gov record NCT00425594. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, parallel, multi-center, single-blind study is designed to compare the safety and efficacy of 3 bowel preparations in pediatric subjects scheduled to undergo a colonoscopy for a routinely accepted indication.

Study identification

NCT ID
NCT00425594
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Braintree Laboratories
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2007 (Type not available)
Primary completion
May 2007 (Actual)
Completion
May 2007 (Actual)
Last update posted
Dec 27, 2007

2007

United States locations

U.S. sites
26
U.S. states
21
U.S. cities
26
Facility City State ZIP Site status
Not listed Birmingham Alabama 35233 —
Not listed Mobile Alabama 36604 —
Not listed Tuscaloosa Alabama 35406 —
Not listed Phoenix Arizona 85016 —
Not listed Little Rock Arkansas 72202 —
Not listed San Francisco California 94143 —
Not listed Gainesville Florida 32610 —
Not listed Orlando Florida 32801 —
Not listed Park Ridge Illinois 60068 —
Not listed Indianapolis Indiana 46202 —
Not listed Boston Massachusetts 02114 —
Not listed Minneapolis Minnesota 55455 —
Not listed Jackson Mississippi 39216 —
Not listed Omaha Nebraska 68198 —
Not listed Las Vegas Nevada 89109 —
Not listed Morristown New Jersey 07962 —
Not listed Buffalo New York 14222 —
Not listed Cleveland Ohio 44106 —
Not listed Columbus Ohio 43205 —
Not listed Lancaster Pennsylvania 17604 —
Not listed Columbia South Carolina 29203 —
Not listed Houston Texas 77030 —
Not listed Temple Texas 76508 —
Not listed Salt Lake City Utah 84113 —
Not listed Burlington Vermont 05401 —
Not listed Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00425594, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 27, 2007 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00425594 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →